English | Español
Patient Daily | Feb 4, 2026

Experimental peptide developed at Hebrew University shows promise for treating recurring epilepsy
Patient Daily | Feb 4, 2026

Oregon State University team develops nanomaterial for targeted cancer cell destruction
Patient Daily | Feb 4, 2026

Japanese scientists identify compound that could help reset body’s internal clock
Patient Daily | Feb 4, 2026

Study finds daily beef consumption does not increase type 2 diabetes risk factors
Patient Daily | Feb 4, 2026

Researchers use routine MRI scans for non-invasive advanced heart failure assessment
Patient Daily | Feb 4, 2026

Study links eating foods high in melatonin to reduced rates of obesity and depression
Patient Daily | Feb 4, 2026

Lifetime heavy drinking increases colorectal cancer risk according to new US study
Patient Daily | Feb 4, 2026

Exploring targeted protein degradation as an emerging tool against antimicrobial resistance

Trending
+ Regulatory
Patient Daily | Apr 16, 2026

Health Analyst: Abuse of 340b drug discount program ‘leaves patients stuck in the middle’

+ Pharmaceuticals
Patient Daily | Apr 14, 2026

Washington Legal Foundation urges Supreme Court to reverse Missouri pesticide labeling ruling
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Kailera Therapeutics announces potential $533 million IPO in obesity drug market
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Novavax shareholder plans to oppose CEO pay and board at upcoming meeting